Published in Circulation on March 01, 1979
The frontiers of cardiomyopathy. Br Heart J (1982) 1.98
Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J Clin Invest (1993) 1.51
Clinical and experimental aspects of viral myocarditis. Clin Microbiol Rev (1989) 1.41
Myocarditis--a case of mistaken identity? Br Heart J (1983) 1.20
Cellular immunity in congestive cardiomyopathy. The normal cellular immune response. Br Heart J (1985) 1.15
HLA antigens in idiopathic dilated cardiomyopathy. Br Heart J (1989) 1.02
Peripartum heart disease: an endomyocardial biopsy study. Br Heart J (1986) 1.01
Acute myocarditis. Role of histological and virological examination in the diagnosis and assessment of immunosuppressive treatment. Br Heart J (1984) 0.99
Evaluation of suppressor immune regulatory function in idiopathic congestive cardiomyopathy and rheumatic heart disease. Br Heart J (1981) 0.95
Familial dilated cardiomyopathy. Br Heart J (1994) 0.86
Do specific HLA antigens predispose to ischaemic heart disease or idiopathic dilated cardiomyopathy? Br Heart J (1994) 0.81
Suppressor T lymphocyte function in patients with idiopathic congestive cardiomyopathy. Br Heart J (1987) 0.80
Myocarditis: some current perspectives and future directions. Tex Heart Inst J (1987) 0.77
Diagnosing and treating active myocarditis. West J Med (1989) 0.77
Dilated cardiomyopathy, myocarditis, and the bioptome. Br Med J (Clin Res Ed) (1986) 0.75
Current treatment of dilated cardiomyopathy. Tex Heart Inst J (1991) 0.75
The authors reply. Br Heart J (1988) 0.75
Pathologic findings in the hearts of patients with acquired immunodeficiency syndrome. Tex Heart Inst J (1991) 0.75
A case of congestive cardiomyopathy. Demonstration at the Royal College of Physicians of London. Br Med J (1980) 0.75
Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts. N Engl J Med (1982) 6.79
The enhancement of macrophage bacteriostasis by products of activated lymphocytes. J Exp Med (1973) 4.51
Heart-lung transplantation: successful therapy for patients with pulmonary vascular disease. N Engl J Med (1982) 4.40
Management of acute aortic dissections. Ann Thorac Surg (1970) 3.66
Cytomegalovirus infection is associated with cardiac allograft rejection and atherosclerosis. JAMA (1989) 2.87
Prosthetic replacement of the aortic arch. J Thorac Cardiovasc Surg (1975) 2.43
The cardiac donor. Surg Gynecol Obstet (1971) 2.39
Infectious complications after cardiac transplantation in man. Ann Intern Med (1971) 2.37
Measurement of serum ferritin by a 2-site immunoradiometric assay. Anal Biochem (1974) 2.37
Sensitivity and specificity of echocardiographic diagnosis of pericardial effusion. Circulation (1974) 2.28
Cardiac transplantation in perspective for the future. Survival, complications, rehabilitation, and cost. J Thorac Cardiovasc Surg (1982) 2.26
A human T lymphocyte differentiation marker defined by monoclonal antibodies that block E-rosette formation. J Immunol (1981) 2.20
Infectious complications among 620 consecutive heart transplant patients at Stanford University Medical Center. Clin Infect Dis (2001) 2.09
Intracoronary ultrasound in cardiac transplant recipients. In vivo evidence of "angiographically silent" intimal thickening. Circulation (1992) 2.04
Nocardial infections in the immunocompromised host: A detailed study in a defined population. Rev Infect Dis (1981) 2.03
Effect of intrathoracic pressure on left ventricular performance. N Engl J Med (1979) 2.01
Multiple valve replacement with the fresh aortic homograft. J Thorac Cardiovasc Surg (1968) 1.90
Treatment of patients with aortic dissection presenting with peripheral vascular complications. Ann Surg (1990) 1.88
Idiopathic cardiomyopathy, age, and suppressor-cell dysfunction as risk determinants of lymphoma after cardiac transplantation. Lancet (1978) 1.87
Diagnosis of human cardiac allograft rejection by serial cardiac biopsy. J Thorac Cardiovasc Surg (1973) 1.82
Cardiac transplantation in man. 3. Surgical aspects. Am J Surg (1969) 1.72
Cardiac transplantation in man. VII. Cardiac allograft pathology. Circulation (1970) 1.65
Primary cardiac neoplasms. Early and late results of surgical treatment in 42 patients. J Thorac Cardiovasc Surg (1987) 1.60
Operative treatment of aortic dissections. Experience with 125 patients over a sixteen-year period. J Thorac Cardiovasc Surg (1979) 1.57
A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med (1993) 1.54
Heart retransplantation: the 25-year experience at a single institution. J Heart Lung Transplant (1996) 1.54
Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study. Circulation (1999) 1.52
Evaluation of heart-lung transplant recipients with prospective, serial transbronchial biopsies and pulmonary function studies. J Thorac Cardiovasc Surg (1989) 1.49
Percutaneous transvenous endomyocardial biopsy in human heart recipients. Experience with a new technique. Ann Thorac Surg (1973) 1.49
Cardiac transplantation in patients with preexisting neoplastic diseases. Am J Cardiol (1990) 1.49
Long-term experience with porcine aortic valve xenografts. J Thorac Cardiovasc Surg (1977) 1.47
Heart and lung transplantation: autotransplantation and allotransplantation in primates with extended survival. J Thorac Cardiovasc Surg (1980) 1.47
Surgical management of aortic dissection during a 30-year period. Circulation (1995) 1.46
Long-term follow-up after isolated aortic valve replacement. J Thorac Cardiovasc Surg (1977) 1.45
Primary and reactivated toxoplasma infection in patients with cardiac transplants. Clinical spectrum and problems in diagnosis in a defined population. Ann Intern Med (1983) 1.45
Transplantation tolerance in adult rats using total lymphoid irradiation: permanent survival of skin, heart, and marrow allografts. J Exp Med (1978) 1.44
Hemodynamic observations one and two years after cardiac transplantation in man. Circulation (1972) 1.42
Frequency and mechanism of bradycardia in cardiac transplant recipients and need for pacemakers. Am J Cardiol (1991) 1.42
Heart transplantation in patients over 54 years of age. Mortality, morbidity and quality of life. Eur Heart J (1997) 1.41
Aspergillus infection complicating cardiac transplantation. Report of five cases. Arch Intern Med (1971) 1.40
Infectious complications in heart-lung transplant recipients. Am J Med (1985) 1.40
Measurement of midwall myocardial dynamics in intact man by radiography of surgically implanted markers. Circulation (1975) 1.40
Clinical utility of two dimensional echocardiography in infective endocarditis. Am J Cardiol (1980) 1.39
Long-term evaluation of the porcine xenograft bioprosthesis. J Thorac Cardiovasc Surg (1979) 1.39
Infectious complications in heart transplant recipients receiving cyclosporine and corticosteroids. Ann Intern Med (1987) 1.38
Echocardiographic findings in discrete subvalvular aortic stenosis. Circulation (1974) 1.38
Alterations in left ventricular twist mechanics with inotropic stimulation and volume loading in human subjects. Circulation (1994) 1.37
Relation between longitudinal, circumferential, and oblique shortening and torsional deformation in the left ventricle of the transplanted human heart. Circ Res (1989) 1.35
Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation (1985) 1.34
Cardiac homotransplantation. Curr Probl Surg (1979) 1.33
Percutaneous transvenous endomyocardial biopsy. JAMA (1973) 1.33
Nocardia infection in heart transplant patients. Ann Intern Med (1975) 1.31
Exercise response of the denervated heart in long-term cardiac transplant recipients. Am J Cardiol (1980) 1.31
Sequential studies of left ventricular function and wall motion after coronary arterial bypass surgery. Am J Cardiol (1980) 1.31
Cardiac transplantation in man. Review of first three years' experience. Am J Med (1973) 1.30
Surgical treatment of postinfarction ventricular septal defects. Ann Thorac Surg (1969) 1.30
Complications in long-term survivors of cardiac transplantation. Transplant Proc (1981) 1.30
Deterioration of myocardial function following aorto-coronary bypass operation. Circulation (1974) 1.29
Alterations in left ventricular diastolic twist mechanics during acute human cardiac allograft rejection. Circulation (1991) 1.29
Intraoperative coronary collateral function in patients with coronary occlusive disease. Nitroglycerin responsiveness and angiographic correlations. Circulation (1974) 1.27
Current trends in lung transplantation. Lobar transplantation and expanded use of single lungs. J Thorac Cardiovasc Surg (1992) 1.26
Profound local hypothermia for myocardial protection during open-heart surgery. J Thorac Cardiovasc Surg (1973) 1.25
Malignant neoplasms following cardiac transplantation. JAMA (1978) 1.24
Effect of volume loading, pressure loading, and inotropic stimulation on left ventricular torsion in humans. Circulation (1991) 1.24
Control of graft arteriosclerosis in human heart transplant recipients. Surgery (1977) 1.21
Two dimensional echocardiographic assessment of patients with bioprosthetic valves. Am J Cardiol (1979) 1.21
Acute renal failure following cardiac surgery. J Thorac Cardiovasc Surg (1979) 1.20
Treatment of endocarditis with valve replacement: the question of tissue versus mechanical prosthesis. Ann Thorac Surg (2001) 1.20
Isolated pulmonary rejection after combined heart-lung transplantation. J Thorac Cardiovasc Surg (1985) 1.19
Study of the normal and failing isolated human heart: decreased response of failing heart to isoproterenol. Am Heart J (1983) 1.19
A two-year experience with human heart transplantation. Calif Med (1970) 1.16
Independent determinants of operative mortality for patients with aortic dissections. Circulation (1984) 1.12
Operative technique for heart-lung transplantation. J Thorac Cardiovasc Surg (1984) 1.12
Clinical experience with a porcine aortic valve xenograft for mitral valve replacement. Ann Thorac Surg (1974) 1.12
Operative treatment of active endocarditis. J Thorac Cardiovasc Surg (1976) 1.11
Hemodynamic observations in the early period after human heart transplantation. J Thorac Cardiovasc Surg (1975) 1.10
Orthotopic heart and combined heart and lung transplantation with cyclosporin-A immune suppression. Transplant Proc (1981) 1.10
Prosthetic valve endocarditis. Comparison of heterograft tissue valves and mechanical valves. J Thorac Cardiovasc Surg (1978) 1.10
Malignant lymphoma in cyclosporin A treated allograft recipients. Lancet (1980) 1.09
Acute rejection of the allogrfted human heart. Ann Thorac Surg (1971) 1.09
Pulmonary artery balloon counterpulsation for acute right ventricular failure. J Thorac Cardiovasc Surg (1980) 1.09
Clinical transplantation of the heart. Ann Surg (1972) 1.09
Detection of ferritin as a circulating tumor-associated antigen in Hodgkin's disease. Natl Cancer Inst Monogr (1973) 1.09
Serial transvenous biopsy of the transplanted human heart. Improved management of acute rejection episodes. Lancet (1974) 1.07
Durability of porcine valves at fifteen years in a representative North American patient population. J Thorac Cardiovasc Surg (1992) 1.07
Endomyocardial biopsy. Ann Intern Med (1982) 1.07
Femoral arterial puncture management after percutaneous coronary procedures: a comparison of clinical outcomes and patient satisfaction between manual compression and two different vascular closure devices. J Invasive Cardiol (2001) 1.07